Extracellular vesicles for cardiovascular therapeutics
In this landmark review, group da Costa Martins and collaborators outline the endogenous properties of EVs that make them natural delivery agents as well as the features that can be improved by bioengineering.
We also discuss the therapeutic applications of native and bioengineered EVs to cardiovascular diseases and examine the opportunities and challenges that need to be addressed to advance this research area, with an emphasis on clinical translation.
Extracellular vesicles are a heterogeneous group of natural particles that are relevant to the treatment of cardiovascular diseases. These endogenous vesicles have certain properties that allow them to survive in the extracellular space, bypass biological barriers and deliver their biologically active molecular cargo to recipient cells. Moreover, EVs can be bioengineered to increase their stability, bioactivity, presentation to acceptor cells and capacity for on-target binding at both cell-type-specific and tissue-specific levels.
Also read
-
SusCheM’s contribution to the Maastricht University Sustainability Report 2025
The publication of the Maastricht University Sustainability Report 2025 marks an important milestone in the university’s sustainability journey. We are proud that our research group contributed to this effort.Corporate andResearchers
-
NWO Veni Grant for Chang Sun
Dr. Chang Sun received an NWO Veni grant for the project "Generative AI for Causal Treatment-Toxicity Analysis in Rare Blood Cancers ".Researchers
-
NWO Open Competition ENW-XS Grant for Joël Karel
Dr. Joël Karel and his colleagues obtained an NWO Open Competition ENW-XS grant for their project " Let the signals self-calibrate: data-driven inverse problem in electrocardiography".Researchers
